Aegis Vopak Terminals Limited has successfully completed its annual secretarial review for the financial year ending March 31, 2026. The report confirms that the company has maintained rigorous standards of corporate governance, transparency, and regulatory compliance throughout the fiscal year. This evaluation by independent professionals serves to validate the company’s commitment to ethical management, robust board processes, and the accurate maintenance of all corporate records and public disclosures.
Commitment to Corporate Governance
Aegis Vopak Terminals Limited has demonstrated a high degree of operational integrity and administrative transparency. The annual review for the period ending March 31, 2026, highlights that the company has upheld strong board processes and maintained a functional compliance mechanism. This ensures that all management activities are aligned with professional standards, protecting the interests of shareholders and stakeholders alike.
Key Compliance Highlights
The review encompassed a comprehensive examination of all corporate documentation, including minute books, filings, and website disclosures. Significant findings include:
- Policy Adherence: All company policies are in full conformity with official guidelines, having been timely reviewed and updated by the Board of Directors.
- Transparency: The company continues to maintain a functional website with timely dissemination of all mandatory documents and information.
- Operational Integrity: No instances of director disqualification were noted, and the company has efficiently managed all performance evaluations for its Board and Committees.
Stakeholder and Audit Integrity
The company has ensured that all related party transactions were processed only after obtaining the necessary prior approvals from the Audit Committee. Furthermore, the review noted that there were no resignations of statutory auditors during the 2025-26 financial year, and no adverse actions were taken against the company, its promoters, or its subsidiaries by major regulatory authorities. This clean bill of health reinforces the company’s focus on maintaining stable and compliant operations as it moves forward in the next fiscal year.
Source: BSE
